American College of Medical Genetics consensus statement on factor V Leiden mutation testing.
作者信息
Grody W W, Griffin J H, Taylor A K, Korf B R, Heit J A
机构信息
Divisions of Medical Genetics and Molecular Pathology, UCLA School of Medicine, Los Angeles, California, USA.
出版信息
Genet Med. 2001 Mar-Apr;3(2):139-48. doi: 10.1097/00125817-200103000-00009.
Abstract
摘要
相似文献
1
American College of Medical Genetics consensus statement on factor V Leiden mutation testing.美国医学遗传学学院关于凝血因子V莱顿突变检测的共识声明。
Genet Med. 2001 Mar-Apr;3(2):139-48. doi: 10.1097/00125817-200103000-00009.
2
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.没有证据表明，因亚甲基四氢叶酸还原酶基因中纯合的677 C至T突变导致的凝血因子V莱顿突变患者静脉血栓形成风险增加。
Blood Coagul Fibrinolysis. 1999 Mar;10(2):101-5. doi: 10.1097/00001721-199903000-00007.
3
[Perioperative management of a patient with factor V Leiden mutation].
Masui. 2003 Apr;52(4):409-11.
4
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.因双重杂合性因子V缺陷（因子V莱顿突变和I型定量因子V缺陷）导致的“假性纯合子”活化蛋白C抵抗与血栓形成相关：两例来自两个无关家族的病例报告
Thromb Haemost. 1996 Mar;75(3):422-6.
5
Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.沙特阿拉伯西部地区因子 V 莱登突变 Arg534Gln 的流行情况：功能改变及与不同人群的关联研究。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620978532. doi: 10.1177/1076029620978532.
6
Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).静脉血栓栓塞症实验室检测（因子 V 莱顿和因子 II c.*97G>A），2018 年更新：美国医学遗传学与基因组学学院（ACMG）的技术标准。
Genet Med. 2018 Dec;20(12):1489-1498. doi: 10.1038/s41436-018-0322-z. Epub 2018 Oct 5.
7
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.杂合子和纯合子因子 V 莱顿突变携带者之间的静脉血栓栓塞事件和复发风险是否真的不同？一项回顾性队列研究。
Eur J Intern Med. 2016 May;30:77-81. doi: 10.1016/j.ejim.2016.02.023. Epub 2016 Mar 9.
8
9
Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.使用在缺乏因子V的血浆中稀释患者血浆的方法对ProC全局检测法进行改良，作为因子V莱顿突变的筛查检测法。
Blood Coagul Fibrinolysis. 2001 Oct;12(7):569-76. doi: 10.1097/00001721-200110000-00010.
10
Determination of activated protein C resistance in anticoagulated and lupus positive patients.抗凝及狼疮阳性患者中活化蛋白C抵抗的测定
Blood Coagul Fibrinolysis. 2000 Jul;11(5):439-45. doi: 10.1097/00001721-200007000-00007.
引用本文的文献
1
Psychotic Disorder Secondary to Cerebral Venous Thrombosis Caused by Primary Thrombophilia in a Pediatric Patient with Protein S Deficiency and an MTHFR p.Ala222Val Variant: A Case Report.一名患有蛋白S缺乏症和MTHFR p.Ala222Val变异的儿科患者因原发性血栓形成倾向导致脑静脉血栓形成继发的精神障碍：病例报告
Hematol Rep. 2025 Jul 3;17(4):34. doi: 10.3390/hematolrep17040034.
2
Inherited thrombophilia transpires with severe coronary arterial thrombosis in wide range of age backgrounds: A report of 3 cases.遗传性血栓形成倾向在广泛年龄背景下伴发严重冠状动脉血栓形成：3例报告
Ann Med Surg (Lond). 2022 May 10;78:103730. doi: 10.1016/j.amsu.2022.103730. eCollection 2022 Jun.
3
The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017-2019.2017-2019 年，沙特国王哈立德大学医院患者中因子 V 莱顿（Arg506Gln）突变的流行率。
Nagoya J Med Sci. 2021 Aug;83(3):407-417. doi: 10.18999/nagjms.83.3.407.
4
Thrombophilic alterations, migraine, and vascular disease: results from a case-control study.血栓形成倾向改变、偏头痛和血管疾病：病例对照研究结果。
Neurol Sci. 2021 Sep;42(9):3821-3828. doi: 10.1007/s10072-020-05006-z. Epub 2021 Jan 20.
5
Direct-to-consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience.消费者直接接受因子 V 莱顿和凝血酶原 20210G>A 基因检测：消费者体验。
Mol Genet Genomic Med. 2020 Nov;8(11):e1468. doi: 10.1002/mgg3.1468. Epub 2020 Sep 16.
6
A curated gene list for reporting results of newborn genomic sequencing.经筛选的基因列表，用于报告新生儿基因组测序结果。
Genet Med. 2017 Jul;19(7):809-818. doi: 10.1038/gim.2016.193. Epub 2017 Jan 12.
7
The Obstetric Medicine Listserv: review of controversies surrounding thrombophilia testing.产科医学邮件列表：关于血栓形成倾向检测相关争议的综述
Obstet Med. 2012 Mar;5(1):22-4. doi: 10.1258/om.2011.110083. Epub 2012 Mar 5.
8
The Frequency of Some Thrombophilic Mutations in Eastern Turkey.土耳其东部某些血栓形成倾向突变的频率。
Eurasian J Med. 2016 Feb;48(1):2-5. doi: 10.5152/eurasianjmed.2015.15007.
9
Recurrent pregnancy loss in a subject with heterozygote factor V Leiden mutation; a case report.一名携带因子V莱顿突变杂合子的患者反复妊娠丢失；病例报告。
Rep Biochem Mol Biol. 2014 Apr;2(2):98-102.
10
Guidance for the evaluation and treatment of hereditary and acquired thrombophilia.遗传性和获得性血栓形成倾向的评估与治疗指南。
J Thromb Thrombolysis. 2016 Jan;41(1):154-64. doi: 10.1007/s11239-015-1316-1.
本文引用的文献
1
Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction.心肌梗死后三至四周行血管造影无明显狭窄的50岁以下患者中因子V莱顿突变和凝血酶原变异体G20210A的患病率。
J Am Coll Cardiol. 2000 Sep;36(3):717-22. doi: 10.1016/s0735-1097(00)00772-5.
2
3
The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
Thromb Haemost. 2000 Feb;83(2):204-8.
4
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.深静脉血栓形成和肺栓塞的危险因素：一项基于人群的病例对照研究。
Arch Intern Med. 2000 Mar 27;160(6):809-15. doi: 10.1001/archinte.160.6.809.
5
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study.深静脉血栓形成和肺栓塞后复发的预测因素：一项基于人群的队列研究。
Arch Intern Med. 2000 Mar 27;160(6):761-8. doi: 10.1001/archinte.160.6.761.
6
Inherited thrombophilia and pregnancy loss.
Thromb Haemost. 1999 Aug;82(2):634-40.
7
Heritable coagulopathies in pregnancy.妊娠期遗传性凝血障碍
Obstet Gynecol Surv. 1999 Dec;54(12):754-65. doi: 10.1097/00006254-199912000-00004.
8
9
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.凝血因子V Leiden和凝血酶原G20210A突变的杂合携带者发生复发性深静脉血栓形成的风险。
N Engl J Med. 1999 Sep 9;341(11):801-6. doi: 10.1056/NEJM199909093411104.
10
Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay.使用均相侵入式微孔板分析法从基因组DNA中进行不依赖聚合酶链反应的因子V莱顿突变检测。
Mol Diagn. 1999 Jun;4(2):135-44. doi: 10.1016/s1084-8592(99)80037-x.
Zotero 插件